Efficacy and Tolerability of BAF312 in Patients With Polymyositis

Condition:   PolymyositisInterventions:   Drug: Placebo;   Drug: BAF312Sponsor:   Novartis PharmaceuticalsRecruiting - verified November 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Polymyositis | Research